Jacques F Banchereau

This inventor holds 47 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 23 EPO patents, primarily in Immunotherapy Techniques. Top assignees: Baylor Research Institute, National Institute of Health and Medical Research, Schering Corporation. Active years: 2002-2026.

USPTO Granted Patents = 47 (Patent Applications = 16)

% Patents Active = 83.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 23 (Patent Applications = 24)

Average Co-Inventor Count = 3.8

ph-index = 12

Forward Citations = 442(Granted Patents)

Location History:

Ecully, FR (2004 - 2011)
Dallas, TX (US) (2002 - 2018)
Montclair, NJ (US) (2013 - 2024)

Company Filing History:

42 out of 96

Baylor Research Institute

patents

3 out of 1,853

National Institute of Health and Medical Research

Agence Nationale De Recherches Sur Le Sida Et Les Hepatitis Virales

patent

5. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

6. 1 out of 236

Université´ D'aix-Marseille

patents

7. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Immunotherapy

Dendritic Cell Vaccines

Anti-CD40 Antibodies

Cancer Antigens

Arthritis Treatments

HIV Antigens

Vaccine Development

Antigen-Presenting Cells

Fusion Proteins

Monoclonal Antibodies

Immunoadjuvants

Hepatitis C Virus

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714745 - AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) (2026-08-25),

2. 12016915 - Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) (2024-06-25),

3. 11806390 - Fusion proteins comprising an anti-CD40 antibody and cancer antigens (2023-11-07),

4. 11406688 - Compositions and methods for the systemic treatment of arthritis (2022-08-09),

5. 11267895 - Nucleic acids encoding anti-CD40 antibodies (2022-03-08),

6. 10988544 - Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides (2021-04-27),

7. 10980869 - Fusion proteins comprising an anti-CD40 antibody and cancer antigens (2021-04-20),

8. 10716832 - Compositions and methods for the systemic treatment of arthritis (2020-07-21),

9. 10683361 - Anti-CD40 antibodies (2020-06-16),

10. 10087256 - Method of making an anti-CD40 antibody (2018-10-02),

11. 10023841 - Methods and compositions for treating breast cancer with dendritic cell vaccines (2018-07-17),

12. 9885017 - Compositions and methods to immunize against hepatitis C virus (2018-02-06),

13. 9862927 - Dendritic cell vaccines (2018-01-09),

14. 9649361 - Compositions and methods for the systemic treatment of arthritis (2017-05-16),

15. 9567401 - Anti-CD40 antibodies (2017-02-14),

Title: Inventor Jacques F. Banchereau

Introduction: Jacques F. Banchereau is a renowned inventor based in Dallas, Texas, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jacques F. Banchereau holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Jacques F. Banchereau has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries.

Collaborations: Throughout his career, Jacques F. Banchereau has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Jacques F. Banchereau's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.